Tarsus Pharmaceuticals, Inc.

The momentum for this stock is not very good. Tarsus Pharmaceuticals, Inc. is not very popular among insiders. Tarsus Pharmaceuticals, Inc. is a mediocre stock to choose.

News

Tarsus Pharmaceuticals (NASDAQ:TARS) Shares Gap Up to $27.31

Ticker Report Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Get Free Report)'s share price gapped up prior to trading on Friday . The stock had previously closed at $27.31, but opened at $28.15. Tarsus...\n more…

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Stocks Shoot Up 35% But Its P/S Still Looks Reasonable

Simply Wall St Those holding Tarsus Pharmaceuticals, Inc. ( NASDAQ:TARS ) shares would be relieved that the share price has rebounded...\n more…

Tarsus Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for TARS

Market News Video In trading on Wednesday, shares of Tarsus Pharmaceuticals Inc (TARS) crossed above their 200 day moving average of 28.32, changing hands as high as 29.50 per share. Tarsus Pharmaceuticals...\n more…

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives $51.17 Average PT from Analysts

Zolmax Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Get Free Report) has received an average recommendation of "Moderate Buy" from the seven brokerages that are covering the company, Marketbeat Ratings...\n more…

Tarsus to Participate in Fireside Chat at the 2024 Wells Fargo Securities Healthcare Conference

Globe Newswire IRVINE, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize...\n more…

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Zolmax Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Get Free Report) have been given a consensus rating of "Moderate Buy" by the seven analysts that are covering the stock, MarketBeat.com reports...\n more…